Search results for "Vaccines"
New research on Pfizer pill, mental disorders after COVID-19, vaccine reactions
A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/1.htm
22 Feb 2022
Q&A: Conquering the ABCs of coding and documentation
Early career physicians may feel overwhelmed by having to document the care they provide, but an expert explains why it's not as confusing as it used to be.
https://immattersacp.org/archives/2024/02/qanda-conquering-the-abcs-of-coding-and-documentation.htm
1 Feb 2024
Progress and limitations on vaccines, strokes and readmissions in COVID-19
A report warned that a few health care workers developed COVID-19 shortly after vaccination, and studies showed that strokes were rare in COVID-19 patients but readmissions could not be predicted easily.
https://immattersacp.org/weekly/archives/2021/02/09/1.htm
9 Feb 2021
Interim data find vaccine 66% to 85% effective against symptomatic RSV in older adults
The results from a large ongoing phase 3 trial show success in protection from respiratory syncytial virus (RSV)-associated lower respiratory tract illness on two important primary endpoints, although reductions in hospitalization and death have yet to be shown.
https://immattersacp.org/weekly/archives/2023/04/11/1.htm
11 Apr 2023
MKSAP Quiz: Evaluation for multiple myeloma
A 64-year-old man is evaluated following a recent diagnosis of multiple myeloma. Chemotherapy is planned to begin in 14 days. Which prophylactic therapy is indicated today?
https://immattersacp.org/weekly/archives/2023/12/05/3.htm
5 Dec 2023
Getting patients to ‘yes' on COVID-19 vaccines
Experts believe practicing physicians are well positioned to take a lead role combating one of the biggest anticipated obstacles to widespread vaccination: vaccine hesitancy.
https://immattersacp.org/archives/2021/01/getting-patients-to-yes-on-covid-19-vaccines.htm
1 Jan 2021
Answers and even more questions on COVID-19 vaccines
In a fourth forum from ACP and Annals of Internal Medicine, infectious disease experts Carlos del Rio, MD, FACP, Paul Sax, MD, and Deborah Cotton, MD, MPH, FACP, discussed COVID-19 vaccines and their implementation, as well as other aspects of the pandemic response.
https://immattersacp.org/weekly/archives/2021/03/30/2.htm
30 Mar 2021
New herpes zoster vaccine brings familiar challenges
A new vaccine should be considered the preferred option for prevention of shingles in adults and should be given in place of the existing one, but it brings with it familiar considerations: efficacy, insurance, and patient communication.
https://immattersacp.org/archives/2018/02/new-herpes-zoster-vaccine-brings-familiar-challenges.htm
1 Feb 2018
Hepatitis B vaccine now recommended for adults ages 19 through 59 years
The Advisory Committee on Immunization Practices has changed its guidance to encourage clinicians to offer the vaccine to adult patients, rather than target those with risk factors or wait for it to be requested.
https://immattersacp.org/weekly/archives/2022/04/05/1.htm
5 Apr 2022
Preparing today for tomorrow's potential pandemic
We all have a responsibility to reflect on our experiences with COVID-19 to identify both the good and the bad, assess the current state of pandemic preparedness, and implement a comprehensive plan.
https://immattersacp.org/archives/2023/09/preparing-today-for-tomorrows-potential-pandemic.htm
1 Sep 2023